JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kono, H.
Right arrow Articles by Thurman, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kono, H.
Right arrow Articles by Thurman, R. G.

Vol. 293, Issue 1, 296-303, April 2000

Allopurinol Prevents Early Alcohol-Induced Liver Injury in Rats1

Hiroshi Kono, Ivan Rusyn , Blair U. Bradford, Henry D. Connor , Ronald P. Mason and Ronald G. Thurman

Laboratory of Hepatobiology and Toxicology, Department of Pharmacology (H.K., I.R., B.U.B., H.D.C., R.G.T.), and Curriculum in Toxicology (I.R., R.P.M., R.G.T.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (H.D.C., R.P.M.)

Free radical formation caused by chronic ethanol administration could activate transcription factors such as nuclear factor-kappa B (NF-kappa B), which regulates production of inflammatory cytokines. Xanthine oxidase is one potential source of reactive oxygen species. Therefore, the purpose of this study is to determine whether allopurinol, a xanthine oxidase inhibitor and scavenger of free radicals, would affect free radical formation, NF-kappa B activation, and early alcohol-induced liver injury in rats. Male Wistar rats were fed a high-fat diet with or without ethanol (10-16 g/kg/day) continuously for up to 4 weeks with the Tsukamoto-French enteral protocol. Either allopurinol or saline vehicle was administered daily. Allopurinol had no effect on body weight or the cyclic pattern of ethanol in urine. Mean urine ethanol concentrations were 271 ± 38 and 252 ± 33 mg/dl in ethanol- and ethanol + allopurinol-treated rats, respectively. In the control group, serum aspartate aminotransferase and alanine aminotransferase levels were ~40 I.U./l and 25 U/l, respectively. Administration of enteral ethanol for 4 weeks increased serum transaminases ~5-fold. Allopurinol blunted these increases significantly by ~50%. Ethanol treatment also caused severe fatty infiltration, mild inflammation, and necrosis. These pathological changes also were blunted significantly by allopurinol. Furthermore, enteral ethanol caused free radical adduct formation, values that were reduced by ~40% by allopurinol. NF-kappa B binding was minimal in the control group but was increased significantly nearly 2.5-fold by ethanol. This increase was blunted to similar values as control by allopurinol. These results indicate that allopurinol prevents early alcohol-induced liver injury, most likely by preventing oxidant-dependent activation of NF-kappa B.


1 This work was supported in part by grants from the National Institute of Alcohol Abuse and Alcoholism.


0022-3565/00/2931-0296$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. E. Jung, M. B. Gatch, and J. W. Simpkins
Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms
Experimental Biology and Medicine, January 1, 2005; 230(1): 8 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Kono, M. Asakawa, H. Fujii, A. Maki, H. Amemiya, M. Yamamoto, M. Matsuda, and Y. Matsumoto
Edaravone, a Novel Free Radical Scavenger, Prevents Liver Injury and Mortality in Rats Administered Endotoxin
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 74 - 82.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Z. Zhou, L. Wang, Z. Song, J. C. Lambert, C. J. McClain, and Y. J. Kang
A Critical Involvement of Oxidative Stress in Acute Alcohol-Induced Hepatic TNF-{alpha} Production
Am. J. Pathol., September 1, 2003; 163(3): 1137 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Kono, T. Uesugi, M. Froh, I. Rusyn, B. U. Bradford, and R. G. Thurman
ICAM-1 is involved in the mechanism of alcohol-induced liver injury: studies with knockout mice
Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1289 - G1295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Kono, I. Rusyn, T. Uesugi, S. Yamashina, H. D. Connor, A. Dikalova, R. P. Mason, and R. G. Thurman
Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat
Am J Physiol Gastrointest Liver Physiol, May 1, 2001; 280(5): G1005 - G1012.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.